Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21-Reference-Cited by-同舟云学术

Effect of Cell-Free DNA Screening vs Direct Invasive Diagnosis on Miscarriage Rates in Women With Pregnancies at High Risk of Trisomy 21

Published:2018-08-14 Issue:6 Volume:320 Page:557
ISSN:0098-7484
Container-title:JAMA
language:en
Short-container-title:JAMA

Author:

Malan Valérie¹²³,Bussières Laurence⁴⁵,Winer Norbert⁶⁷,Jais Jean-Philippe³⁸,Baptiste Amandine⁵,Le Lorc’h Marc¹,Elie Caroline⁵,O’Gorman Neil³⁴,Fries Nicolas⁹¹⁰,Houfflin-Debarge Véronique⁷¹¹,Sentilhes Loic⁷¹²¹³,Vekemans Michel¹³,Ville Yves³⁴,Salomon Laurent J.³⁴⁷¹⁰,

Affiliation:

1. Department of Histology-Embryology and Cytogenetics, Hôpital Necker–Enfants Malades, AP-HP, Paris, France

2. INSERM U1163, Hôpital Necker–Enfants Malades, Paris, France

3. Paris Descartes University, Sorbonne Paris Cité, Institut Imagine, Paris, France

4. Department of Obstetrics and Gynecology, Hôpital Necker–Enfants Malades, AP-HP, Paris, France

5. Clinical Unit Research/Clinic Investigation Center, Paris Descartes, Hôpital Necker–Enfants Malades, AP-HP, Paris, France

6. Department of Obstetrics and Gynecology, CHU de Nantes, UMR 1280 PHAN (Physiologie des Adaptations Nutritionnelles), INRA University, Nantes, France

7. Groupe de Recherche en Obstétrique et Gynécologie (GROG), Paris, France

8. Department of Biostatistics and Medical Informatics, Hôpital Necker–Enfants Malades, AP-HP, Paris, France

9. Department of Obstetrics and Gynecology, CHU de Montpellier, Montpellier, France

10. Collège Français d’Echographie Fœtale (CFEF), Chateaubriand, France

11. Department of Obstetrics and Gynecology, CHU de Lille, Lille, France

12. Department of Obstetrics and Gynecology, CHU d’Angers, Angers, France

13. Department of Obstetrics and Gynecology, CHU de Bordeaux, Bordeaux, France

Publisher

American Medical Association (AMA)

Subject

General Medicine

Reference36 articles.

1. First trimester ultrasound tests alone or in combination with first trimester serum tests for Down’s syndrome screening.;Alldred;Cochrane Database Syst Rev,2017

2. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis.;Gil;Ultrasound Obstet Gynecol,2017

3. Cell-free DNA analysis for noninvasive examination of trisomy.;Norton;N Engl J Med,2015

4. ISUOG updated consensus statement on the impact of cfDNA aneuploidy testing on screening policies and prenatal ultrasound practice.;Salomon;Ultrasound Obstet Gynecol,2017

5. Committee opinion summary No. 640: cell-free DNA screening for fetal aneuploidy.;Obstet Gynecol,2015

Cited by 49 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Prenatal diagnosis after high chance non-invasive prenatal testing for trisomies 21, 18 and 13, chorionic villus sampling or amniocentesis? – Experience at a district general hospital in the United Kingdom;European Journal of Obstetrics & Gynecology and Reproductive Biology: X;2023-09

2. A call for public funding of invasive and non-invasive prenatal testing;Journal of Perinatal Medicine;2023-05-22

3. First Trimester Screening Tests Pregnancy and Trisomy 13 Syndrome, Sex Chromosome Aneuploidy in Iran: A Cross-Sectional Study;INT J FERTIL STERIL;2023

4. First Trimester Screening Tests Pregnancy and Trisomy 13 Syndrome, Sex Chromosome Aneuploidy in Iran: A Cross-Sectional Study;INT J FERTIL STERIL;2023

5. Comparison of K-means and DBSCAN for prediction determination of Down syndrome using prenatal test data;5TH INTERNATIONAL CONFERENCE ON INNOVATIVE DESIGN, ANALYSIS & DEVELOPMENT PRACTICES IN AEROSPACE & AUTOMOTIVE ENGINEERING: I-DAD’22;2023